In the News |
March 3, 2026
Kivu Bioscience Appoints Brunilda Shtylla Chief Business Officer

Kivu Bioscience is naming Brunilda Shtylla Chief Business Officer, with Shtylla assuming the same role she held at Sutro Biopharma. Shtylla is tasked with leading corporate strategy, business development, and partnership initiatives as Kivu advances its antibody-drug conjugate (ADC) pipeline.